RPG LIFE SCIENCES share price has zoomed 16% and is presently trading at Rs 2,744.0.
Meanwhile, the BSE HEALTHCARE index is at 42,991.5 (up 0.4%).
Among the top gainers in the BSE HEALTHCARE index today are Procter & Gamble Health (up 2.5%) and SUN PHARMA ADV. RES. (up 2.0%).
Dr. Reddys (down 79.8%) and ERIS LIFESCIENCES (down 3.3%) are among the top losers today.
Over the last one year, RPG LIFE SCIENCES has moved up from Rs 1,363.8 to Rs 2,744.0, registering a gain of Rs 1,380.2 (up 101.2%).
On the other hand, the BSE HEALTHCARE index has moved up from 27,318.2 to 42,991.5, registering a gain of 57.4% during the last 12 months.
The top gainers among the BSE HEALTHCARE index stocks during this same period were Jubilant Pharmova (up 221.0%), Glenmark Pharma (up 122.3%) and SUVEN PHARMACEUTICALS (up 120.1%).
Dear Reader: If You Invest in Midcap Stocks, this is for You
The BSE Sensex is at 79,703.8 (up 0.4%).
The top gainers among the BSE Sensex today are ICICI Bank (up 2.6%) and NTPC (up 1.2%). The most traded stocks in the BSE Sensex are HDFC Bank and Tata Steel.
In the meantime, NSE Nifty is at 24,249.7 (up 0.3%). Shriram Transport and ICICI Bank are among the top gainers in NSE NIFTY.
Over the last 12 months, the BSE Sensex has moved up from 64,049.1 to 79,703.8, registering a gain of 15,654.7 points (up 24.4%).
RPG LIFE SCIENCES net profit grew 21.1% YoY to Rs 268 million for the quarter ended June 2024, compared to a profit of Rs 221 million a year ago. Net sales rose 11.9% to Rs 1,654 million during the period as against Rs 1,478 million in April-June 2023.
For the year ended March 2024, RPG LIFE SCIENCES reported 29.6% increase in net profit to Rs 877 million compared to net profit of Rs 676 million during FY23. Revenue of the company grew 13.5% to Rs 5,821 million during FY24.
The current Price to earnings ratio of RPG LIFE SCIENCES, based on rolling 12 month earnings, stands at 49.2.
Equitymaster requests your view! Post a comment on "RPG LIFE SCIENCES Gains 16%; BSE HEALTHCARE Index Up 0.4%". Click here!
Comments are moderated by Equitymaster, in accordance with the Terms of Use, and may not appear
on this article until they have been reviewed and deemed appropriate for posting.
In the meantime, you may want to share this article with your friends!